Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 6, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Thyroid Eye Disease
Interventions
OTHER

Observational cohort study

Observational cohort study

DRUG

Batoclimab

Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody

Trial Locations (55)

114

RECRUITING

Site Number - 3454, Tbilisi

RECRUITING

Site Number - 3455, Tbilisi

159

RECRUITING

Site Number - 3450, Tbilisi

RECRUITING

Site Number - 3451, Tbilisi

1070

RECRUITING

Site Number - 4672, Brussels

1133

RECRUITING

Site Number - 7550, Budapest

1200

RECRUITING

Site Number - 4673, Brussels

2000

RECRUITING

Site Number - 7565, Sydney

7623

RECRUITING

Site Number - 7552, Pécs

8000

RECRUITING

Site Number - 4671, Bruges

8006

RECRUITING

Site Number - 3602, Barcelona

8013

RECRUITING

Site Number - 7570, Christchurch

15706

RECRUITING

Site Number - 3600, Santiago de Compostela

20122

RECRUITING

Site Number - 6204, Milan

20149

RECRUITING

Site Number - 6203, Milan

26506

RECRUITING

Site Number - 1511, Morgantown

28034

RECRUITING

Site Number - 3604, Madrid

41009

RECRUITING

Site Number - 3606, Seville

46026

RECRUITING

Site Number - 3603, Valencia

48152

RECRUITING

Site Number - 1526, Livonia

53226

RECRUITING

Site Number - 1518, Milwaukee

55905

RECRUITING

Site Number - 1513, Rochester

56124

RECRUITING

Site Number - 6201, Pisa

75149

RECRUITING

Site Number - 1558, Mesquite

77030

RECRUITING

Site Number - 1508, Houston

80045

RECRUITING

Site Number - 1501, Aurora

80131

RECRUITING

Site Number - 6205, Napoli

82606

RECRUITING

Site Number - 9200, Bratislava

89184

RECRUITING

Site Number - 1540, Las Vegas

90127

RECRUITING

Site Number - 6209, Palermo

91101

RECRUITING

Site Number - 9202, Trenčín

91120

RECRUITING

Site Number - 4761, Jerusalem

91741

COMPLETED

Site Number - 1520, Glendora

1834111

RECRUITING

Site Number - 4764, Afula

4941492

RECRUITING

Site Number - 4762, Petah Tikva

5265601

RECRUITING

Site Number - 4760, Ramat Gan

B-9000

RECRUITING

Site Number - 4670, Ghent

CAP95125

RECRUITING

Site Number - 6207, Catania

00189

RECRUITING

Site Number - 6202, Rome

LV-5001

RECRUITING

Site Number - 9301, Ogre

LV-1006

RECRUITING

Site Number - 9300, Riga

LV3601

RECRUITING

Site Number - 9302, Ventspils

44-102

RECRUITING

Site Number - 3107, Gliwice

30-688

RECRUITING

Site Number - 3101, Krakow

20-171

RECRUITING

Site Number - 3104, Lublin

60-354

RECRUITING

Site Number - 3105, Lublin

00921

RECRUITING

Site Number - 1990, San Juan

Unknown

RECRUITING

Site Number - 9201, Bratislava

GU2 7XX

RECRUITING

Site Number - 7305, Guildford

EC1V 2PD

RECRUITING

Site Number - 7303, London

W1T 6AH

RECRUITING

Site Number - 7312, London

W1T 7HA

RECRUITING

Site Number - 7313, London

M139WL

RECRUITING

Site Number - 7300, Manchester

NE1 3BZ

ACTIVE_NOT_RECRUITING

Site Number - 7302, Newcastle upon Tyne

S102SB

RECRUITING

Site Number - 7308, Sheffield

Sponsors
All Listed Sponsors
lead

Immunovant Sciences GmbH

INDUSTRY

NCT05517447 - Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease | Biotech Hunter | Biotech Hunter